Perception Prognosis, Goals of Treatment, and Communication

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01401894
Collaborator
(none)
50
1
44
1.1

Study Details

Study Description

Brief Summary

The purpose of this research study is to assess what the participant understands about their illness, prognosis, the goals of the cancer treatment and their communication with their oncology providers. This study will help us to figure out how the investigators can improve how other patients understand their illness and goals of treatment and help us improve communication with their doctors. This research is being done because there is not a lot of information on how much patients understand about their illness and prognosis.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    • Participants will be asked to answer a few basic questions regarding race, ethnicity, religion, relationship status, education, income, and living situation.

    • They will then be asked to complete a questionnaire which contains questions about their mood, spirituality, quality of life and their understanding of their treatment and prognosis and their communication with their oncologist. They will complete these questionnaires in the clinic or infusion room on one of their regularly scheduled visit.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    50 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Pilot Study to Investigate Advanced Cancer Patient's Perspective of Their Prognosis, Goals of Treatment, and Quality of Communication With Their Oncologists
    Study Start Date :
    Oct 1, 2010
    Actual Primary Completion Date :
    Oct 1, 2012
    Actual Study Completion Date :
    Jun 1, 2014

    Outcome Measures

    Primary Outcome Measures

    1. Completion of surveys [1 year]

    Secondary Outcome Measures

    1. Patients perceptions of prognosis, goals of care, and communication with providers [1 year]

    2. Quality of end of life care [1 year]

    3. Survival [1 year]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Confirmed new diagnosis of advanced gastric, esophageal, pancreatic, and hepatobiliary cancer, not being treated with curative intent.

    • Planning to receive chemotherapy at Massachusetts General Hospital

    • Ability to read and respond to questions in English.

    Exclusion Criteria:
    • Prior chemotherapy for current stage of disease.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Massachusetts General Hospital Boston Massachusetts United States 02114

    Sponsors and Collaborators

    • Massachusetts General Hospital

    Investigators

    • Principal Investigator: Jennifer Temel, MD, Massachusetts General Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    El-Jawahri, Areej,M.D., Director MGH BMT Survivorship Program, Massachusetts General Hospital
    ClinicalTrials.gov Identifier:
    NCT01401894
    Other Study ID Numbers:
    • 10-219
    First Posted:
    Jul 25, 2011
    Last Update Posted:
    Jan 31, 2017
    Last Verified:
    Jan 1, 2017
    Keywords provided by El-Jawahri, Areej,M.D., Director MGH BMT Survivorship Program, Massachusetts General Hospital

    Study Results

    No Results Posted as of Jan 31, 2017